These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37441388)

  • 1. Recent advances in CD8
    Arenas VR; Rugeles MT; Perdomo-Celis F; Taborda N
    Heliyon; 2023 Jun; 9(6):e17481. PubMed ID: 37441388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing CD8
    Warren JA; Clutton G; Goonetilleke N
    Front Immunol; 2019; 10():291. PubMed ID: 30863403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.
    Delannoy A; Poirier M; Bell B
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CXCR5
    Gao L; Zhou J; Ye L
    Front Microbiol; 2022; 13():998058. PubMed ID: 36452930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.
    Berendam SJ; Nelson AN; Goswami R; Persaud D; Haigwood NL; Chahroudi A; Fouda GG; Permar SR
    Curr HIV/AIDS Rep; 2020 Jun; 17(3):237-248. PubMed ID: 32356090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies.
    Rutishauser RL; Trautmann L
    Curr Opin HIV AIDS; 2022 Sep; 17(5):315-324. PubMed ID: 35777930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of CD8
    McBrien JB; Kumar NA; Silvestri G
    Eur J Immunol; 2018 Jun; 48(6):898-914. PubMed ID: 29427516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure.
    Berendam SJ; Nelson AN; Yagnik B; Goswami R; Styles TM; Neja MA; Phan CT; Dankwa S; Byrd AU; Garrido C; Amara RR; Chahroudi A; Permar SR; Fouda GG
    Front Immunol; 2022; 13():885272. PubMed ID: 35911681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Collins DR; Gaiha GD; Walker BD
    Nat Rev Immunol; 2020 Aug; 20(8):471-482. PubMed ID: 32051540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kill: boosting HIV-specific immune responses.
    Trautmann L
    Curr Opin HIV AIDS; 2016 Jul; 11(4):409-16. PubMed ID: 27054280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Perdomo-Celis F; Taborda NA; Rugeles MT
    Front Immunol; 2019; 10():1896. PubMed ID: 31447862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.
    Vieira VA; Herbert N; Cromhout G; Adland E; Goulder P
    Front Immunol; 2022; 13():886562. PubMed ID: 35634290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elite control of HIV: is this the right model for a functional cure?
    Cockerham LR; Hatano H
    Trends Microbiol; 2015 Feb; 23(2):71-5. PubMed ID: 25487109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological approaches to HIV cure.
    Ward AR; Mota TM; Jones RB
    Semin Immunol; 2021 Jan; 51():101412. PubMed ID: 32981836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T-cell immunity to HIV infection.
    Piazza P; Fan Z; Rinaldo CR
    Clin Lab Med; 2002 Sep; 22(3):773-97. PubMed ID: 12244597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of HBV-Specific CD8
    Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
    Front Immunol; 2019; 10():2240. PubMed ID: 31620140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Th17 cells in HIV-1 remission/cure interventions.
    Fert A; Raymond Marchand L; Wiche Salinas TR; Ancuta P
    Trends Immunol; 2022 Jul; 43(7):580-594. PubMed ID: 35659433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.